Krilogy Financial LLC Invests $1.06 Million in Danaher Corporation $DHR

Krilogy Financial LLC acquired a new stake in Danaher Corporation (NYSE:DHR) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 4,991 shares of the conglomerate’s stock, valued at approximately $1,059,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. WFA of San Diego LLC purchased a new stake in Danaher during the second quarter valued at about $26,000. Howard Hughes Medical Institute bought a new stake in shares of Danaher in the 2nd quarter valued at about $27,000. TruNorth Capital Management LLC purchased a new stake in Danaher during the 3rd quarter valued at about $28,000. Tripletail Wealth Management LLC bought a new position in Danaher during the 3rd quarter worth approximately $31,000. Finally, Heartwood Wealth Advisors LLC purchased a new position in Danaher in the 3rd quarter worth approximately $37,000. Institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

DHR has been the subject of a number of analyst reports. Barclays increased their price objective on Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. The Goldman Sachs Group dropped their price target on shares of Danaher from $270.00 to $265.00 and set a “buy” rating for the company in a research report on Thursday, January 29th. Argus set a $265.00 price target on shares of Danaher in a report on Wednesday, January 14th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Finally, Robert W. Baird set a $251.00 target price on Danaher in a research note on Thursday, January 29th. Twenty research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $253.86.

Danaher Trading Down 2.3%

NYSE:DHR opened at $214.92 on Friday. The company has a 50-day moving average price of $228.91 and a 200-day moving average price of $215.40. The stock has a market cap of $151.81 billion, a price-to-earnings ratio of 42.64, a P/E/G ratio of 2.97 and a beta of 0.91. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The company had revenue of $6.84 billion during the quarter, compared to the consensus estimate of $6.79 billion. During the same period in the prior year, the firm earned $2.14 earnings per share. Danaher’s revenue was up 4.6% on a year-over-year basis. Equities analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, December 26th were paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Friday, December 26th. Danaher’s dividend payout ratio (DPR) is presently 25.40%.

Insider Buying and Selling at Danaher

In related news, Director Teri List sold 3,298 shares of the company’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total value of $746,997.00. Following the sale, the director directly owned 20,762 shares of the company’s stock, valued at $4,702,593. This represents a 13.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 11.10% of the stock is owned by corporate insiders.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.